CAS 4829-46-3
:(5alpha,6alpha)-3-methoxy-17-methyl-7,8-didehydro-4,5-epoxymorphinan-6,14-diol
7,8-Didehydro-4,5α-epoxy-3-methoxy-17-methylmorphinan-6α,14-diol (14-Hydroxycodeine)
CAS:Kontrolliertes ProduktFormel:C18H21NO4Farbe und Form:NeatMolekulargewicht:315.3614-Hydroxycodeine
CAS:Kontrolliertes ProduktApplications An impurity of Codeine (C634075), a weak narcotic analgesic.
References Eddy, S., et al.: J. Pharmacol. Exp. Ther., 67, 127 (1939), Muhtadi, F.J., et al.: Anal. Profiles Drug Subs., 10, 93 (1981).Formel:C18H21NO4Farbe und Form:NeatMolekulargewicht:315.3614-Hydroxycodeine (1 mg/ml in Acetonitrile)
CAS:Kontrolliertes ProduktFormel:C18H21NO4Farbe und Form:Single SolutionMolekulargewicht:315.3614-Hydroxycodeine-d3
CAS:Kontrolliertes ProduktFormel:C18D3H18NO4Farbe und Form:NeatMolekulargewicht:318.382Codeine Impurity F
CAS:Kontrolliertes ProduktCodeine Impurity F is a biochemical that is an impurity of codeine. Codeine Impurity F is a byproduct of the enzymatic reaction with morphine and the bacterial strain Pseudomonas putida. Codeine Impurity F has been shown to inhibit the growth of gram-negative bacteria, including Escherichia coli and Salmonella enterica, by binding to cellular membranes and inhibiting their function. It also binds to RNA in vitro and prevents translation of mRNA from its ribosome complex. The hydroxyl group on Codeine Impurity F binds to aluminium ions, which may interfere with the absorption of other drugs such as ampicillin or tetracycline. This impurity has been shown to have an effect on biological products such as immunoglobulins and albumin.
Formel:C18H21NO4Reinheit:Min. 95%Molekulargewicht:315.36 g/molRef: 3D-FC161072
Ausgelaufenes produkt


